States »EasPosted at: May 14 2021 4:56PM

Dr. Reddy’s Laboratories announces launch of Sputnik V vaccine in Indian Market

Kolkata, May 14 (UNI) Dr. Reddy’s Laboratories Ltd. on Saturday announced that the first
consignment of imported doses of the Sputnik V vaccine that landed in India on May 1,
received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13.
As part of a limited pilot, the soft launch of the vaccine has commenced and the first
dose of the vaccine was administered in Hyderabad on Friday, a company official here
said.
Further consignments of imported doses are expected over the upcoming months.
Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing
partners.
The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5% GST
per dose, with the possibility of a lower price point when local supply begins.The Company
is working closely with its six manufacturing partners in India to fulfill regulatory requirements
to ensure smooth and timely supply.
Dr. Reddy’s will work closely with stakeholders in the Government and private sector in
India to ensure the widest possible reach of the Sputnik V vaccine as part of the national
inoculation effort. This is a reaffirmation of the Company’s commitment to explore every
avenue in the fight against the COVID-19 pandemic in India.
GV Prasad, Co-Chairman and Managing Director, said, “With the rising cases in India,
vaccination is our most effective tool in our battle against COVID-19.Contributing to the
vaccination drive in Indiais ourbiggest priorityright now to help Indians be healthy and
safe.”
UNI BM